Yu Fan

Prof. Yu Fan


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
NFNa Fang
Na Fang
MJMenglin Jiang
Menglin Jiang
YFYu Fan
Yu Fan

20 November 2013 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
JXJ. Xu
J. Xu
DGD.D. Gong
D.D. Gong
CMC.F. Man
C.F. Man
YFYu Fan
Yu Fan
To evaluate the existing prospective observational studies on the morality risk among Parkinson's disease (PD) patients and determine the overall risk ratio (RR) of mortality by conducting a meta-analysis and systematic review. Original articles published in English were searched in PubMed and Embase databases prior to March 2013. Only prospective observational studies providing adjusted risk estimates related to PD and future mortality were considered eligible. Pooled adjusted RR and 95% confidence interval (CI) were computed either by fixed-effects models or by random-effects models. Eight studies with 72,833 participants were identified and analysed. In the pooled analyses, patients with PD had a greater risk of all-cause mortality (RR = 2.22; 95% CI: 1.78-2.77). Subgroup analyses based on the design, gender, follow-up duration and sample size showed that a consistent positive association between PD and the mortality risk in each subgroup. However, no statistical significance was found for the baseline age <65 years (RR = 1.42; 95% CI: 0.72-2.77). PD patients with dementia had particularly high mortality risks (RR = 3.78; 95% CI: 2.06-6.92). This meta-analysis indicated that among patients with PD, the all-cause mortality increased by 2.22-fold compared with the general population. PD patients with dementia particularly had higher risks of mortality.

11 January 2015 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
HPHui-Yong Peng
Hui-Yong Peng
CMChang-Feng Man
Chang-Feng Man
JXJuan Xu
Juan Xu
YFYu Fan
Yu Fan
To investigate whether elevated homocysteine levels were a predictor of subsequent coronary heart disease (CHD) mortality, cardiovascular mortality or all-cause mortality in the general population by a metaanalysis. In a systematic search conducted in the databases of PubMed and Embase prior to October 2013, we identified relevant prospective observational studies evaluating the association between baseline homocysteine levels and CHD mortality, cardiovascular or all-cause mortality in the general population. Pooled adjust risk ratio (RR) and corresponding 95% confidence interval (CI) were calculated separately for categorical risk estimates and continuous risk estimates. Twelve studies with 23 623 subjects were included in the meta-analysis. Comparing the highest to lowest homocysteine level categories, CHD mortality increased by 66% (RR 1.66; 95% CI 1.12–2.47; P=0.012), cardiovascular mortality increased by 68% (RR 1.68; 95% CI 1.04–2.70; P=0.033), and all-cause mortality increased by 93% (RR 1.93; 95% CI 1.54–2.43; P<0.001). Moreover, for each 5 μmol/L homocysteine increment, the pooled RR was 1.52 (95% CI 1.26–1.84; P<0.001) for CHD mortality, 1.32 (95% CI 1.08–1.61; P=0.006) for cardiovascular mortality, and 1.27 (95% CI 1.03–1.55; P=0.023) for all-cause mortality. Elevated homocysteine levels are an independent predictor for subsequent cardiovascular mortality or all-cause mortality, and the risks were more pronounced among elderly persons. 探讨普通人群血浆同型半胱氨酸水平升高是否能独立预测死亡风险。 通过汇总12篇前瞻性研究, 定量分析血浆同型半胱氨酸水平升高与心血管疾病及各种死亡风险因子的关系。 通过检索PubMed和Embase数据库, 收集普通人群中血浆同型半胱氨酸水平与死亡关系的前瞻性观察性研究, 采用STATA统计软件进行meta分析。 血浆同型半胱氨酸水平升高是心血管疾病及各种原因死亡风险增加的一个独立预测因素, 在老年人群中尤为明显。

1 May 2016 in Clinical Biochemistry
Verified
Journal Article
Closed access
YZYongjing Zhou
Yongjing Zhou
FWFeifei Wei
Feifei Wei
YFYu Fan
Yu Fan

12 July 2022 in Clinical Nutrition
Verified
Journal Article
Closed access
JXJuan Xu
Juan Xu
YJYu Jie
Yu Jie
YSYimeng Sun
Yimeng Sun
DGDandan Gong
Dandan Gong
YFYu Fan
Yu Fan

1 May 2016 in Medicine
Verified
Journal Article
Open access
NFNa Fang
Na Fang
MJMenglin Jiang
Menglin Jiang
YFYu Fan
Yu Fan
The association between psoriasis and carotid intima-media thickness (CIMT) or impaired flow-mediated dilation (FMD) remains controversial. We aimed to evaluate the extent of subclinical atherosclerosis as measured by CIMT and FMD in patients with psoriasis by conducting a meta-analysis.A systematic literature search was performed using PubMed, Embase, Cochrane databases, China National Knowledge Infrastructure, and VIP databases up to February 2015. Observational studies investigating CIMT or FMD in patients with psoriasis and controls were eligible. Psoriatic patients and controls were at least age- and sex-matched. Random-effects analysis was used to estimate the weighted mean difference (WMD) and 95% confidence interval (CI) between psoriatic patients and controls.A total of 20 studies were identified and analyzed. Meta-analysis showed that psoriatic patients had a significantly thicker CIMT (WMD 0.11 mm; 95% CI 0.08-0.15) and lower FMD (WMD -2.79%; -4.14% to -1.43%) than those in controls. Subgroup analysis indicated that psoriatic arthritis appeared to have less impaired FMD (WMD -2.45%) and thinner CIMT (WMD 0.10 mm). Psoriatic patients with mean age >45 years had much thicker CIMT (WMD 0.13 mm). The impaired FMD (WMD -3.99%) seemed more pronounced in psoriatic patients with mean age <45 years.This meta-analysis suggests that patients with psoriasis are associated with excessive risk of subclinical atherosclerosis. Screening and monitoring CIMT and brachial artery FMD may be recommended to identify a subgroup of psoriatic patients at higher risk for cardiovascular events.